Study of AMV564 in Subjects With Advanced Solid Tumors

Clinical trial NCT04128423 · UNKNOWN

Trial details

NCT number: NCT04128423
Sponsor: Amphivena Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2019-10-09
Primary completion: 2021-12-15
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.